De novo asymmetric synthesis of D- and L-swainsonine

Organic Letters

Volumn 8, Issue 8, 2006, Pages 1609-1612

  Guo, Haibing ^a   O'Doherty, George A ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PALLADIUM; SWAINSONINE;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; GLYCOSYLATION; STEREOISOMERISM; SYNTHESIS;

CATALYSIS; GLYCOSYLATION; MOLECULAR STRUCTURE; PALLADIUM; STEREOISOMERISM; SWAINSONINE;

EID: 33646438221     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol0602811     Document Type: Article

References (45)

1. (a) Asano, N.; Nash, R. J.; Molyneux, R. J.; Fleet, G. W. J. Tetrahedron: Asymmetry 2000, 11, 1645-1680.
2. (b) Michael, J. P. Nat. Prod. Rep. 1997, 14, 619-636.
3. For a review of iminosugars, see: (a) Sears, P.; Wong, C.-H. Angew. Chem., Int. Ed. 1999, 38, 2300-2324.
4. (b) Tyler, P. C.; Winchester, B. G. Iminosugars as Glycosidase Inhibitors 1999, 125-156.
5. (c) Burgess, K.; Henderson, I. Tetrahedron 1992, 48, 4045-66.
6. (d) Fellows, L. E.; Kite, G. C.; Nash, R. J.; Simmonds, M. S. J.; Scofield, A. M. Rec. Adv. Phytochem. 1989, 23, 395-427.
7. For a review of swainsonine syntheses, see: (a) Nemr, A. E. Tetrahedron 2000, 56, 8579-8629.
8. For more recent syntheses, see: (b) Martin, R.; Murruzzu, C.; Pericas, M. A.; Riera, A. J. Org. Chem. 2005, 70, 2325-2328.
9. (c) Heimgaertner, G.; Raatz, D.; Reiser, O. Tetrahedron 2005, 61, 643-655.
10. (d) Song, L.; Duesler, E. N.; Mariano, P. S. J. Org. Chem. 2004, 69, 7284-7293.
11. (e) Lindsay, K. B.; Pyne, S. G. Aust. J. Chem. 2004, 57, 669-672.
12. (f) Pearson, W. H.; Ren, Y.; Powers, J. D. Heterocycles 2002, 58, 421-430.
13. (g) Lindsay, K. B.; Pyne, S. G. J. Org. Chem. 2002, 67, 7774-7780.
14. (h) Buschmann, N.; Rueckert, A.; Blechert, S. J. Org. Chem. 2002, 67, 4325-4329.
15. (i) Zhao, H.; Hans, S.; Cheng, X.; Mootoo, D. R. J. Org. Chem. 2001, 66, 1761-1767.
16. Ali, M. H.; Hough, L.; Richardson, A. C. J. Chem. Soc., Chem. Commun. 1984, 447-448.
17. Fleet, G. W. J.; Gough, M. J.; Smith, P. W. Tetrahedron Lett. 1984, 25, 1853-1856.
18. Suami, T.; Tadano, K.; Iimura, Y. Chem. Lett. 1984, 513-516.
19. Adams, C. E.; Walker, F. J.; Sharpless, K. B. J. Org. Chem. 1985, 50, 420-422.
20. Bennett, R. B.; Choi, J. R.; Montgomery, W. D.; Cha, J. K. J. Am. Chem. Soc. 1989, 111, 2580-2582.
21. Pearson, W. H.; Membre, E. J. J. Org. Chem. 1996, 61, 7217-7221.
22. (a) Oishi, T.; Iwakuma, T.; Hirama, M.; Ito, S. Synlett 1995, 404-406.
23. (b) Davis, B.; Bell, A. A.; Nash, R. J.; Watson, A. A.; Griffiths, R. C.; Jones, M. G.; Smith, C.; Fleet, G. W. J. Tetrahedron Lett. 1996 37, 8565-8568.
24. For the bioactivities of swainsonine, see: (a) Elbein, A. D. FASEB J. 1991, 5, 3055-3063.
25. (b) Goss, P. E.; Reid, C. L.; Bailey, D.; Dennis, J. W. Clin. Cancer Res. 1997, 3, 11077-11086.
26. (c) Galustian, C.; Foulds, S.; Dye, J. F.; Guillou, P. J. Immunopharmacol. 1994, 27, 165-172.
27. (d) Grzegorzewski, K.; Newton, S. A.; Akiyama, S. K.; Sharrow, S.; Olden, K.; White, S. L. Cancer Commun. 1989, 1, 373-279.
28. (e) Elbein, A. D. Annu. Rev. Biochem 1987, 56, 497-534.
29. (f) Cenci Di Bello, I.; Fleet, G.; Namgoong, S. K.; Tadano, K.; Winchester, B. Biochem. J. 1989, 259, 855-861.
30. (g) Winchester, B.; Fleet, G. W. J. Glycobiology 1992, 2, 199-210.
31. (h) Tulsiani, D. R. P.; Harris, T. M.; Touster, O. J. Biol. Chem. 1982, 257, 7936-7939.
32. (i) Kino, T.; Inamura, N.; Nakahara, K.; Kiyoto, S.; Goto, T.; Terano, H.; Kohsaka, M. J. Antibiot. 1985, 38, 936-940.
33. An Achmatowicz reaction is the oxidative rearrangement of furyl alcohols to 2-substituted 6-hydroxy-2H-pyran-3(6H)-ones; see: (a) Achmatowicz, O.; Bielski, R. Carbohydr. Res. 1977, 55, 165-176.
34. For its recent use in carbohydrate synthesis, see: (b) Guo, H.; O'Doherty, G. A. Org. Lett. 2005, 7, 3921-3924 and references therein.
35. In the Fleet synthesis of swainsonine a similar reductive amination was employed; see ref 5.
36. While we have prepared both D- and L-swainsonine, for simplicity herein we only show the L-enantiomer.
37. 3N (1:1 instead of 2:1) was required for the Noyori reduction of compounds with primary TBS groups; see: Li, M.; Scott, J. G.; O'Doherty, G. A. Tetrahedron Lett. 2004, 45, 1005-1009.
38. (a) Babu, R. S.; O'Doherty, G. A. J. Am. Chem. Soc. 2003, 125, 12406-12407.
39. (b) Babu, R. S.; Zhou, M.; O'Doherty, G. A. J. Am. Chem. Soc. 2004, 126, 3428-3429.
40. (c) Babu, R. S.; O'Doherty, G. A. J. Carbohydr. Chem. 2005, 24, 169-177.
41. de Oliveira, R. N.; Cottier, L.; Sinou, D.; Srivastava, R. M. Tetrahedron 2005, 61, 8271-8281.
42. Presumably, because of the rigid nature of the 7 and the equatorial nature of the allylic azide no [3,3] sigmatropic rearrangement was observed; see: Feldman, A. K.; Colasson, B.; Sharpless, K. B.; Fokin, V. V. J. Am. Chem. Soc. 2005, 127, 13444-13445.
43. (a) Hudlicky, T.; Abboud, K. A.; Bolonick, J.; Maurya, R.; Stanton, M. L.; Thorpe, A. J. Chem. Commun. 1996, 1717-1718.
44. (b) Takao, K.-I.; Hara, M.; Tsujita, T.; Yoshida, K.-I.; Tadano, K.-I. Tetrahedron Lett. 2001, 42, 4665-4668.
45. By simply switching the (S,S)-Noyori reagent for the reduction of 10 to (ent)-9 to the (R,R)-Noyori reagent (10 to 9), D-swainsonine was prepared from 9 in nearly identical overall yield.